# Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain

> **NCT00003348** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 56 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** O6-benzylguanine
- **DRUG:** carmustine

## Key facts

- **NCT ID:** NCT00003348
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 2000-08
- **Final completion:** 2000-08
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2013-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003348, "Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00003348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*